The AI Molecule

Artificial intelligence is reducing the time and cost required to discover new drug candidates. New forms of late-stage capital are allowing better companies to stay independent longer. Direct-to-patient distribution is weakening Pharma’s control of the commercial channel. Together, these changes alter the architecture of biotechnology. The molecule is being separated from the old machine that used to deliver it. This is a structural change in how drugs are discovered, financed, developed, negotiated, and delivered. Biotech companies will build discovery systems, develop clinical evidence, control proprietary data, preserve financing options, and reach patients more directly.

The Application Layer

Artificial intelligence is a stack: energy, silicon, cloud, models, and applications. Each has its own economics, competitive dynamics, and challenges. Mistaking one layer for the whole industry causes confusion, misrepresentation, bad decisions, and misguided capital allocations. The infrastructure builders enable the platform; the application builders capture the value. The question is now, what value does all this deliver? Energy, silicon, cloud, and models only serve to deliver that product. There is a robust argument that we are at the beginning of an unprecedented value-creation curve. Built on the infrastructure and services provided by the other layers of the stack, the AI application layer will be globally transformative and disruptive. The constraints are imagination, execution, and the willingness to rebuild how work is done.

The New Software Stack

For the better part of three decades, enterprise software followed a remarkably stable economic logic. You built a product. You sold access to that product. You charged per seat. You expanded revenue by increasing the number of people required to operate the system.
It was elegant, scalable, and wildly profitable. Now, it is breaking. It is the decoupling of software revenue from human labor. The industry continues to frame this moment as a competition between AI and software. That framing is wrong. AI is not competing with software. It is becoming the operating system for work.